More recently, he has held consulting, advisory and investment partner roles with organisations including BIO, MIT, Roivant ...

Roivant Sciences Ltd (NASDAQ:ROIV) is set to release its Q2 2025 earnings on Nov 12, 2024. The consensus estimate for Q2 2025 ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) today. The company’s shares ...

Vivek Ramaswamy (American entrepreneur who founded Roivant Sciences) will also be very influential and will surely support ...

As Donald Trump secures the 2024 U.S. presidency, prominent Indian-Americans, including Sundar Pichai, Satya Nadella, and Nikki Haley, share their congratulations and optimism for the future. These ...

AB-101-001 is a Phase 1a/1b double-blind, randomized, placebo-controlled clinical trial designed to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single- ...

Strive Enterprises, a financial services company co-founded by former Republican presidential candidate Vivek Ramaswamy, has announced plans to move its headquarters to Dallas.

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

The U.S. is deploying a total of six nuclear equipped B-52s, an additional squadron of F-15E Strike Eagles, and more aerial ...

Strive Enterprises, co-founded by the former Republican presidential candidate, is also launching a wealth management ...

An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug ...

“I would like to thank Kevin and the entire Organon team for their partnership in the acquisition of Dermavant,” said Mayukh Sukhatme, MD, President and Chief Investment Officer of Roivant.